Illumina sequencing and array technologies drive advances in life science research, translational and consumer genomics, and molecular diagnostics.

Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for …

Find the latest Illumina, Inc. (ILMN) stock quote, history, news and other vital information to help you with your stock trading and investing.

5 days ago · Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function.

6 days ago · Illumina was founded in 1998 and has become a leader in sequencing and array solutions for genetic analysis, all having great potential to revolutionize healthcare, which can have massive ...

5 days ago · Illumina TruSight™ Oncology Comprehensive is now reimbursed through the Centers for Medicare and Medicaid Services; enabling broader access to precision oncology solutions for …

1 day ago · Rakuten Investment Management Inc. bought a new stake in Illumina, Inc. (NASDAQ:ILMN - Free Report) during the third quarter, according to its most recent filing with the Securities and …

2 days ago · Illumina's recent CMS reimbursement win and alliances around its Billion Cell Atlas and Connected Multiomics platform come after a sharp 50.11% 3 month share price return. In contrast, …

5 days ago · What Is Driving the Updated Illumina Price Target? Illumina's fair value estimate has been revised from about US$119.84 to about US$132.06 per share, based on slightly higher assumptions …

At Illumina, we are expanding access to genomic technology to realize health equity for billions of people around the world and transform human health. Our impact is everywhere, from the early detection …